The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-life use of G-CSF in patients with small cell lung cancer (SCLC): Secondary data analysis from the French national cohorts KBP-ESCAP-2020-CPHG.
 
Lionel Falchero
No Relationships to Disclose
 
Florian Scotte
Honoraria - Amgen; BMS GmbH & Co. KG; Daichy Sankyo; Gilead Sciences; GlaxoSmithKline; Leo Phar; Pfizer; Pharmanovia; Thermofisher Scientific Biomarkers; Viatris
Research Funding - Gilead Sciences
Travel, Accommodations, Expenses - Pfizer
 
Sébastien Couraud
Honoraria - AstraZeneca; Bristol-Myers Squibb; Janssen; Pfizer
Expert Testimony - Amgen; BMS GmbH & Co. KG; Boehringer Ingelheim; Janssen; MSD; Novartis; Pierre Fabre; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Chiesi; Janssen; Roche; Takeda
 
Karima Menia
Employment - Chugai Pharma
 
Didier Debieuvre
Honoraria - Amgen; AstraZeneca; BMS France; Janssen; MSD; Pfizer; Roche; Sanofi/Regeneron; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; BMS France; Janssen; MSD Oncology; Pfizer; Sanofi/Aventis
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BMS france (Inst); Chugai Pharma (Inst); Janssen (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Janssen Oncology; MSD Oncology; PharmaMar; Takeda